文献速递关节外科创伤骨科

静态与活动型间隔物治疗全膝关节置换术后感染的随机试验

A Randomized Trial of Static and Articulating Spacers for the Treatment of Infection Following Total Knee Arthroplasty.
PubMed 文献 · J Bone Joint Surg Am · 2020-01-01

这项多中心随机临床试验比较了静态与活动型抗生素间隔物在二期翻修治疗慢性全膝关节置换术后假体周围感染中的效果。结果显示活动型间隔物组在平均3.5年随访时活动弧和膝关节协会评分显著更高,而静态组在取出感染假体后住院时间更长。当软组织包膜允许且有足够骨支撑时,活动型间隔物与更好的结局相关。

要点

  • 活动型间隔物组平均活动弧113.0°,显著高于静态组的100.2°(p=0.001)。
  • 活动型间隔物组膝关节协会评分79.4分,显著高于静态组的69.8分(p=0.043)。
  • 静态组在取出感染假体后住院时间比活动组多1天(6.1 vs 5.1天,p=0.032)。

核心结论

  • 活动型间隔物在平均3.5年时提供了显著更大的活动范围和更高的膝关节协会评分。
  • 静态间隔物与取出感染假体后更长的住院时间相关。
  • 当软组织包膜允许且有足够骨支撑时,活动型间隔物与更好的结局相关。

研究设计与样本

  • 患者随机接受静态间隔物(32例)或活动型间隔物(36例)作为二期翻修的一部分。
  • 先验效能分析确定每组需28例患者以检测组间13°的活动范围差异。

主要发现

  • 静态组在第一步手术后住院时间比活动组多1天(6.1 vs 5.1天;95%CI分别为5.3-6.9天和4.6-5.6天;p=0.032)。
  • 平均3.5年(范围2.0-6.4年)时49例患者可评估,活动型间隔物组平均活动弧113.0°(95%CI 108.4°-117.6°),静态组100.2°(95%CI 94.2°-106.1°)(p=0.001)。
  • 活动型间隔物组平均膝关节协会评分79.4分(95%CI 72.4-86.3),静态组69.8分(95%CI 63.6-76.1)(p=0.043)。
  • 静态组再植入时需要广泛暴露的比例为16.7%(95%CI 0.6%-38.9%),活动组为4.0%(95%CI 0.5%-26.3%)(p=0.189)。
  • 静态组再手术率为25.0%(95%CI 9.8%-46.7%),活动组为8.0%(95%CI 1.0%-26.0%)(p=0.138)。

临床怎么用

  • 在软组织包膜允许且有足够骨支撑的条件下,可优先考虑使用活动型间隔物以改善活动范围和膝关节功能。

局限性

  • 随机化后6例被排除,6例死亡,7例在2年前失访,最终仅49例纳入平均3.5年分析。
  • 广泛暴露需求和再手术率的差异在研究样本量下未达统计学显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is no consensus whether the interim antibiotic spacer utilized in the 2-stage exchange arthroplasty should immobilize the joint or allow for motion. The purpose of this multicenter, randomized clinical trial was to compare static and articulating spacers as part of the 2-stage exchange arthroplasty for the treatment of chronic periprosthetic joint infection complicating total knee arthroplasty as defined with use of Musculoskeletal Infection Society criteria. METHODS: Sixty-eight patients undergoing 2-stage exchange arthroplasty were randomized to either a static (32 patients) or an articulating (36 patients) spacer. An a priori power analysis determined that 28 patients per group would be necessary to detect a 13° difference in range of motion between groups. Six patients were excluded after randomization, 6 died, and 7 were lost to follow-up before 2 years. RESULTS: Patients in the static group had a hospital length of stay that was 1 day greater than the articulating group after stage 1 (6.1 compared with 5.1 days; 95% confidence interval [CI], 5.3 to 6.9 days and 4.6 to 5.6 days, respectively; p = 0.032); no other differences were noted perioperatively. At a mean of 3.5 years (range, 2.0 to 6.4 years), 49 patients were available for evaluation. The mean motion arc was 113.0° (95% CI, 108.4° to 117.6°) in the articulating spacer group, compared with 100.2° (95% CI, 94.2° to 106.1°) in the static spacer group (p = 0.001). The mean Knee Society Score was higher in the articulating spacer cohort (79.4 compared with 69.8 points; 95% CI, 72.4 to 86.3 and 63.6 to 76.1, respectively; p = 0.043). Although not significantly different with the sample size studied, static spacers were associated with a greater need for an extensile exposure at the time of reimplantation (16.7% compared with 4.0%; 95% CI, 0.6% to 38.9% and 0.5% to 26.3%, respectively; p = 0.189) and a higher rate of reoperation (25.0% compared with 8.0%; 95% CI, 9.8% to 46.7% and 1.0% to 26.0%, respectively; p = 0.138). CONCLUSIONS: Articulating spacers provided significantly greater range of motion and higher Knee Society scores at a mean of 3.5 years. Static spacers were associated with a longer hospital stay following removal of the infected implant. When the soft-tissue envelope allows and if there is adequate osseous support, an articulating spacer is associated with improved outcomes. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Nahhas CR, Chalmers PN, Parvizi J, et al. A Randomized Trial of Static and Articulating Spacers for the Treatment of Infection Following Total Knee Arthroplasty. J Bone Joint Surg Am. 2020. PMID: 32379118. doi:10.2106/JBJS.19.00915

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。